Beijing Chunlizhengda proposes governance overhaul, supervisory committee abolished

Beijing Chunlizhengda Medical Instruments Co. announced proposed amendments to its articles of association and rules of procedures, alongside the abolishment of its supervisory committee. These changes aim to comply with amendments to the Company Law of the People's Republic of China, effective July 1, 2024, and align with new regulatory requirements for expanded paperless listing regimes.

The company's board of directors has approved resolutions for these proposed amendments, which include the transfer of the supervisory committee's functions and powers to the audit committee. These amendments also address electronic dissemination of corporate communications by listed issuers.

The proposed amendments require approval by special resolutions from shareholders at an extraordinary general meeting. A circular detailing these changes and the EGM notice has been published on the company's and Stock Exchange's websites. The announcement was made on December 9, 2025.